文章基本信息

标题：Author Correction: Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation
本地全文：下载
作者：Noam Shohat ; Karan Goswami ; Leigham Breckenridge 等
期刊名称：Scientific Reports
电子版ISSN：2045-2322
出版年度：2021
卷号：11
DOI：10.1038/s41598-021-94867-1
语种：English
出版社：Springer Nature
摘要：Correction to: Scientific Reports 10.1038/s41598-021-81803-6, published online 26 January 2021 The original version of this Article contained an error in Table 2, where in columns “Total cohort (n = 1212)” and “Fasting plasma glucose ≥ 100 mg/dL (n = 423)”, the n values for ‘Normal fructosamine’ and ‘High fructosamine’ were accidently switched. The correct and incorrect heading rows appear below. Incorrect: Complications Total cohort (n = 1212) Fasting plasma glucose ≥ 100 mg/dL (n = 423) Normal fructosamine (n = 54) High fructosamine (n = 1158) p value Normal fructosamine (n = 32) High fructosamine (n = 391) p value Correct: Complications Total cohort (n = 1212) Fasting plasma glucose ≥ 100 mg/dL (n = 423) Normal fructosamine (n = 1158) High fructosamine (n = 54) p value Normal fructosamine (n = 391) High fructosamine (n = 32) p value The original Article has been corrected.